BTCY Utang jangka cendhak perusahaan Biotricity, Inc.

The market capitalization trend for Biotricity, Inc. (BTCY) reflects debt dynamics currently priced at 0.00. Biotricity, Inc. (BTCY) is developing high-precision Bioflux AI sensors for 24/7 cardiac monitoring. Revenue is based on recurring subscriptions for monitoring access, ensuring a steady cash flow. Despite digital restrictions, the business successfully focuses on the protected markets of the US and friendly nations.

The remote cardiac monitoring SaaS model of Biotricity, Inc. (BTCY) ensures a stable cash flow, yet the current volume of short-term liabilities allows for a real-time assessment of this liquidity's actual sustainability. This indicator aggregates all borrowings with maturities of up to one year, helping investors determine whether the company's operating income can cover immediate debt payments without resorting to emergency external financing or equity dilution.